{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:50:15Z","timestamp":1749703815541,"version":"3.37.3"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010805","name":"FORSS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009753","name":"Region J\u00f6nk\u00f6ping County","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T03:10:14Z","timestamp":1709608214000},"page":"618-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-7210","authenticated-orcid":false,"given":"Jan","family":"S\u00f6derman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-1821","authenticated-orcid":false,"given":"Sven","family":"Almer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gastha.2024.02.009_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/ecco-jcc\/jjab085","article-title":"Immunological networks defining the heterogeneity of inflammatory bowel diseases","volume":"15","author":"Selin","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ibd\/izy238","article-title":"Defining failure of medical therapy for inflammatory bowel disease","volume":"25","author":"Volk","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastha.2024.02.009_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ecco-jcc\/jjac003","article-title":"Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-naive inflammatory bowel disease","volume":"16","author":"Juzenas","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-001003","article-title":"Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD","volume":"10","author":"Verstockt","year":"2023","journal-title":"BMJ Open Gastroenterol"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib8","first-page":"1260","article-title":"Genome-wide pathway analysis using gene expression data of colonic mucosa in patients with inflammatory bowel disease","volume":"21","author":"Palmieri","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"13","key":"10.1016\/j.gastha.2024.02.009_bib9","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.3390\/ijms23136944","article-title":"Inverse and concordant mucosal pathway gene expressions in inflamed and non-inflamed ulcerative colitis patients: potential relevance to aetiology and pathogenesis","volume":"23","author":"Soderman","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","article-title":"Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn's disease","volume":"159","author":"Mitsialis","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.009_bib11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gutjnl-2019-318343","article-title":"A\u00a0blood-based prognostic biomarker in IBD","volume":"68","author":"Biasci","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib12","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.3390\/ijms24065820","article-title":"Differences in whole-blood transcriptional profiles in inflammatory bowel disease patients responding to vedolizumab compared with non-responders","volume":"24","author":"Haglund","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10080","key":"10.1016\/j.gastha.2024.02.009_bib13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gastha.2024.02.009_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/CEG.S343468","article-title":"Mucosal gene transcript signatures in treatment naive inflammatory bowel disease: a comparative analysis of disease to symptomatic and healthy controls in the European IBD-character cohort","volume":"15","author":"Vatn","year":"2022","journal-title":"Clin Exp Gastroenterol"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","article-title":"Reliability and initial validation of the ulcerative colitis endoscopic index of severity","volume":"145","author":"Travis","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ibd.21480","article-title":"Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity","volume":"17","author":"Thia","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib18","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1038\/s41467-018-07242-6","article-title":"Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases","volume":"9","author":"Vallania","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap","volume":"14","author":"Reimand","year":"2019","journal-title":"Nat Protoc"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/gepi.21797","article-title":"Estimating genome-wide significance for whole-genome sequencing studies","volume":"38","author":"Xu","year":"2014","journal-title":"Genet Epidemiol"},{"issue":"18","key":"10.1016\/j.gastha.2024.02.009_bib21","first-page":"4219","article-title":"Inflammatory bowel disease and neutrophil-lymphocyte ratio: a systematic scoping review","volume":"10","author":"Langley","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.gastha.2024.02.009_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231155987","article-title":"Pursuing neutrophils: systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease","volume":"16","author":"Magalhaes","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2016-313535","article-title":"CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcmgh.2021.03.002","article-title":"Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation","volume":"12","author":"Drury","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"675","key":"10.1016\/j.gastha.2024.02.009_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq4473","article-title":"Targeting cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2022","journal-title":"Sci Transl Med"},{"issue":"Suppl 2","key":"10.1016\/j.gastha.2024.02.009_bib27","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ecco-jcc\/jjab188","article-title":"Evolution of IL-23 blockade in inflammatory bowel disease","volume":"16","author":"Danese","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023765","article-title":"Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.gastha.2024.02.009_bib29","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1053\/j.gastro.2021.02.062","article-title":"Therapeutic interleukin-6 trans-signaling inhibition by Olamkicept (sgp130Fc) in patients with active inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gastha.2024.02.009_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2023.1084","article-title":"Effect of induction therapy with Olamkicept vs placebo on clinical response in patients with active ulcerative colitis: a randomized clinical trial","volume":"329","author":"Zhang","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-3083.2011.02592.x","article-title":"Resistin is associated with breach of tolerance and anti-nuclear antibodies in patients with hepatobiliary inflammation","volume":"74","author":"Bostrom","year":"2011","journal-title":"Scand J Immunol"},{"issue":"12","key":"10.1016\/j.gastha.2024.02.009_bib33","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/MEG.0b013e3282f16251","article-title":"Resistin is an inflammatory marker of inflammatory bowel disease in humans","volume":"19","author":"Konrad","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.009_bib34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2011-300820","article-title":"Flt3 ligand expands CD103(+) dendritic cells and FoxP3(+) T regulatory cells, and attenuates Crohn's-like murine ileitis","volume":"61","author":"Collins","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib35","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1038\/s41598-019-45747-2","article-title":"Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: a Mendelian randomization study","volume":"9","author":"Mokry","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2024.02.009_bib36","first-page":"1","article-title":"Acute onset of inflammatory colitis in overlap with psoriatic arthritis and systemic lupus erythematosus following treatment with secukinumab","volume":"7","author":"Almer","year":"2021","journal-title":"J\u00a0Transl Sci"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233781","article-title":"Risk for development of inflammatory bowel disease under inhibition of interleukin 17: a systematic review and meta-analysis","volume":"15","author":"Burisch","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.gastha.2024.02.009_bib38","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/annrheumdis-2020-217927","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"79","author":"Fauny","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib39","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1053\/j.gastro.2021.12.288","article-title":"Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease","volume":"162","author":"Abraham","year":"2022","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103331","article-title":"Cytokines and intestinal epithelial permeability: a systematic review","volume":"22","author":"Meyer","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.gastha.2024.02.009_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fcell.2018.00008","article-title":"Signaling through the primary cilium","volume":"6","author":"Wheway","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.it.2022.03.001","article-title":"Primary cilia and their effects on immune cell functions and metabolism: a model","volume":"43","author":"Picon-Galindo","year":"2022","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ydbio.2018.07.024","article-title":"The ciliary protein Rpgrip1l in development and disease","volume":"442","author":"Wiegering","year":"2018","journal-title":"Dev Biol"},{"issue":"11","key":"10.1016\/j.gastha.2024.02.009_bib44","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1136\/annrheumdis-2013-204050","article-title":"Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis","volume":"73","author":"Knevel","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib45","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4049\/jimmunol.1401166","article-title":"Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis","volume":"193","author":"de Bock","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10072-019-04165-y","article-title":"Identification of distinct blood-based biomarkers in early stage of Parkinson's disease","volume":"41","author":"Wu","year":"2020","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib47","first-page":"92","article-title":"Ribosomal proteins: functions beyond the ribosome","volume":"7","author":"Zhou","year":"2015","journal-title":"J\u00a0Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.gastha.2024.02.009_bib48","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1093\/nar\/gkac053","article-title":"Deficiency of ribosomal proteins reshapes the transcriptional and translational landscape in human cells","volume":"50","author":"Luan","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.gastha.2024.02.009_bib49","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1201933","article-title":"An extraribosomal function of ribosomal protein L13a in macrophages resolves inflammation","volume":"190","author":"Poddar","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bab.2538","article-title":"Cationic ribosomal proteins can inhibit pro-inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products","volume":"71","author":"Watanabe","year":"2024","journal-title":"Biotechnol Appl Biochem"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13391","article-title":"The tRNA-associated dysregulation in immune responses and immune diseases","volume":"228","author":"Zhu","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"issue":"7422","key":"10.1016\/j.gastha.2024.02.009_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2006.06.135","article-title":"Syntaxin 16 controls the intracellular sequestration of GLUT4 in 3T3-L1 adipocytes","volume":"347","author":"Proctor","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A\u00a0ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gastha.2024.02.009_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110507","article-title":"The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease","volume":"129","author":"Ghafouri-Fard","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib56","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s10620-020-06417-w","article-title":"LncRNA: a potential research direction in intestinal barrier function","volume":"66","author":"Jiang","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","article-title":"Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology","volume":"143","author":"Smith","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MIB.0000000000000209","article-title":"Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel","volume":"21","author":"Goncalves","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10620-015-3932-1","article-title":"Association between long-term lipid profiles and disease severity in a large cohort of patients with inflammatory bowel disease","volume":"61","author":"Koutroumpakis","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/joim.12855","article-title":"Oxysterols in intestinal immunity and inflammation","volume":"285","author":"Willinger","year":"2019","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11894-022-00840-x","article-title":"Impact of obesity on inflammatory bowel disease","volume":"24","author":"Khakoo","year":"2022","journal-title":"Curr Gastroenterol Rep"},{"issue":"10","key":"10.1016\/j.gastha.2024.02.009_bib62","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ibd\/izaa062","article-title":"Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF: neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio","volume":"26","author":"Bertani","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12876-023-03043-4","article-title":"Platelet\/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1572-0241.2001.03621.x","article-title":"Mean platelet volume: a useful marker of inflammatory bowel disease activity","volume":"96","author":"Kapsoritakis","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib65","first-page":"348","article-title":"Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review","volume":"33","author":"Katsaros","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.009_bib66","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1189\/jlb.0807513","article-title":"Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis","volume":"84","author":"Lampinen","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmed.2023.01.001","article-title":"IBD disease-modifying therapies: insights from emerging therapeutics","volume":"29","author":"Kotla","year":"2023","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-023-05750-y","article-title":"ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib69","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib70","first-page":"76","article-title":"H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p\/PCBP2 axis","volume":"14","author":"Ma","year":"2021","journal-title":"J\u00a0Ovarian Res"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.009_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061857","article-title":"Syntaxin 16 regulates lumen formation during epithelial morphogenesis","volume":"8","author":"Jung","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.gastha.2024.02.009_bib72","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.bbamcr.2017.09.005","article-title":"Transcription factor CUX1 is required for intestinal epithelial wound healing and targets the VAV2-RAC1 Signalling complex","volume":"1864","author":"Latreille","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib73","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ecco-jcc\/jjz213","article-title":"Regulation of Janus Kinase 2 by an inflammatory bowel disease causal non-coding single nucleotide polymorphism","volume":"14","author":"Cardinale","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.009_bib74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MIB.0000000000001035","article-title":"Epithelial-specific toll-like receptor (TLR)5 activation mediates barrier dysfunction in experimental ileitis","volume":"23","author":"Lopetuso","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib75","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2018.01.079","article-title":"Deficiency of primary cilia in kidney epithelial cells induces epithelial to mesenchymal transition","volume":"496","author":"Han","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ecco-jcc\/jjv138","article-title":"Renal involvement in inflammatory bowel diseases","volume":"10","author":"Corica","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.009_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14740\/gr990w","article-title":"Hepatobiliary manifestations and complications in inflammatory bowel disease: a review","volume":"11","author":"Fousekis","year":"2018","journal-title":"Gastroenterology Res"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.009_bib78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12876-022-02634-x","article-title":"Common laboratory blood test immune panel markers are useful for grading ulcerative colitis endoscopic severity","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.gastha.2024.02.009_bib79","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/MIB.0000000000000144","article-title":"Implications of the colonic deposition of free hemoglobin-alpha chain: a previously unknown tissue by-product in inflammatory bowel disease","volume":"20","author":"Myers","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.009_bib80","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.gastha.2024.02.009_bib81","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1053\/j.gastro.2010.02.044","article-title":"Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease","volume":"138","author":"Bouchaud","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gastha.2024.02.009_bib82","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.41655","article-title":"Contribution of a European-prevalent variant near CD83 and an East asian-prevalent variant near IL17RB to herpes zoster risk in tofacitinib treatment: results of genome-wide association study meta-analyses","volume":"73","author":"Bing","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"18","key":"10.1016\/j.gastha.2024.02.009_bib83","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gastha.2024.02.009_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.intimp.2018.04.010","article-title":"Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice","volume":"59","author":"Luo","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.gastha.2024.02.009_bib85","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A\u00a0cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.009_bib86","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/gutjnl-2019-318512","article-title":"Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?","volume":"69","author":"Garg","year":"2020","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.009_bib87","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.gastha.2024.02.009_bib88","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/acs.molpharmaceut.2c00255","article-title":"A\u00a0colon-targeted prodrug of Riluzole improves therapeutic effectiveness and safety upon drug repositioning of Riluzole to an anti-colitic drug","volume":"19","author":"Park","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.gastha.2024.02.009_bib89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2020.02.017","article-title":"Statins and inflammatory bowel disease: where do we stand?","volume":"75","author":"Peppas","year":"2020","journal-title":"Eur J Intern Med"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277257232400030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277257232400030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T08:26:14Z","timestamp":1721118374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277257232400030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"alternative-id":["S277257232400030X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2024.02.009","relation":{},"ISSN":["2772-5723"],"issn-type":[{"type":"print","value":"2772-5723"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}